Search results

Found 245 pages
AUTHOR: Katrina Megget

Results per page

10 20 50 100

Sort by

Relevance Date

4 Apr 2014:

Genomics issues in a new era for pharma

Advances in genomics will change the way pharma discovers, regulates and reimburses new medicines, Amgen’s R&D head in Europe has said. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/genomics_issues_in_a_new_era_for_pharma_1001770

4 Jan 2013:

39 drugs approved in the USA in 2012

US Drug approvals in 2012 have reached a 15-year high with regulators giving the thumbs up to 39 new drugs. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/39_drugs_approved_in_the_usa_in_2012_1004164

7 Jul 2009:

Novo diabetes drug launched in UK

The potential “holy grail” to treat diabetes has been launched in the UK. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/novo_diabetes_drug_launched_in_uk_984533

13 Mar 2013:

NHS launches health app library

The NHS Commissioning Board has launched a library of NHS-reviewed health apps to help people manage their health. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/nhs_launches_health_app_library_1004626

11 Feb 2011:

Pharma’s R&D future is questioned

Pharmaceutical R&D needs a shake-up like never before in a bid to secure a future for itself, the chief executive of Eli Lilly has urged the industry. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/pharmas_r_and_d_future_is_questioned_979610

10 Aug 2012:

Dutch setback for Cosmo's ulcerative colitis drug

The Dutch Regulatory Agency has declined Cosmo Pharmaceuticals’ ulcerative colitis drug Cortiment (budesonide with MMX technology), which has lead to the Italian company’s stock falling as much as 12%. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/dutch_setback_for_cosmos_ulcerative_colitis_drug_976814

15 Oct 2008:

GSK moves into Egypt for $210 million

GlaxoSmithKline is acquiring Bristol Myers Squibb’s mature products business in Egypt for $210 million. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/gsk_moves_into_egypt_for_$210_million_986591

29 Oct 2012:

UK warned of a 'stroke crisis'

The UK is at risk of developing a stroke crisis as risk factors for the condition are under-diagnosed and under-treated. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/uk_warned_of_a_stroke_crisis_976353

18 Jun 2009:

Sanofi donates flu vaccine to developing countries

Sanofi-Aventis is to donate 100 million doses of influenza vaccine to the World Health Organisation to help developing countries face the swine flu pandemic. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/sanofi_donates_flu_vaccine_to_developing_countries_984658

3 May 2013:

Welsh CRO accesses new investment fund

The new Wales Life Sciences Investment Fund has made its first investment, backing Merthyr Tydfil-based clinical research organisation Simbec Research. - News - PharmaTimes

by Katrina Megget

https://www.pharmatimes.com/news/welsh_cro_accesses_new_investment_fund_1004959